TruthArchive.ai - Related Video Feed

We were all hopeful when we heard the vaccine was 95% effective, thinking it was our way out. But maybe we were too optimistic and not cautious enough. We didn't consider the possibility of the vaccine wearing off or being less effective against future variants.

The speaker asks if the Pfizer COVID vaccine was tested for its ability to stop virus transmission before being released. They request a clear yes or no answer and the data to be shared with the committee. The response states that they did not have prior knowledge of stopping transmission before the vaccine entered the market and had to rely on scientific research. Another speaker expresses outrage, claiming that people were pressured to get vaccinated based on the false belief that it would protect others.

The speaker emphasizes the lengthy process of developing a safe and effective vaccine, usually taking 10 to 25 years. They mention a potential safety issue with coronavirus vaccines, where immunization may lead to immune enhancement when exposed to the virus. This phenomenon has been observed in laboratory animals. Despite this concern, the speaker expresses enthusiasm for the approval of the second vaccine, stating that if enough Americans get vaccinated, virus transmission could be halted. They also mention the availability of new boosters, recommending anyone who is safe to get them for added protection.

The speakers emphasize the importance of vaccination in reducing transmission and returning to normalcy. They mention that vaccinated individuals do not carry the virus or get sick. Getting vaccinated and receiving booster shots can save lives, protect loved ones, and prevent the spread of infection. The vaccines effectively stop the virus with each vaccinated person, preventing it from using them as a host to infect others. However, the speakers acknowledge that the initial data on vaccine transmission was limited, and they did not have a clear answer on whether the vaccines would stop infection. They stress the need for people to take the vaccines to break the chain of transmission.

The speaker expresses disappointment that the existence of myocarditis was known very early on. They claim to have written to Fauci in 2020 and 2021 about lymphopenia and the failure to clear the virus, asserting that this failure was also known early on. The speaker states the perception of 95% efficacy was inaccurate and suggests there were perverse incentives at play, and now the consequences must be recognized. Another speaker then states that this is why Fauci needed a pardon.

The speaker discusses the contagiousness of Covid-19 and the presence of two variants, Eris and Pirola. They mention that current vaccines and those being proposed seem to be effective against these variants. However, they clarify that the vaccines may not prevent transmission completely, but they do prevent severe cases. The speaker emphasizes that there is a recommendation, not an obligation, for people over 65 and those with immunodeficiencies or comorbidities to get vaccinated. They address concerns about vaccine effectiveness for transmission and acknowledge that there are side effects, but they do not have specific statistics. The speaker calls for transparency regarding vaccine limitations and side effects to maintain credibility. They suggest that the government should communicate this information officially.

The speaker claims the vaccine saved hundreds of thousands of lives but acknowledges side effects and breakthrough infections. The speaker argues that the vaccine was claimed to stop transmission and infection, but it did not. An argument ensues with someone who disagrees, with accusations of being crazy and shutting up. The speaker denies using ad hominem attacks.

Speaker 0 asks if the vaccine prevented people from getting COVID. Speaker 1 believes it lessened symptom severity and reduced emergency room visits, a view supposedly held by 90% of objective experts. Speaker 0 regrets getting vaccinated, fearing he would miss his son's birth. He got COVID a couple of weeks after vaccination and received conflicting test results, questioning the competence of the testers.

The speaker acknowledges that the vaccine did not completely stop the spread or infection, but clarifies that initially it did for the Wuhan strain and the alpha strain. Early data and literature published in the New England Journal showed that those who were vaccinated and didn't get infected were not transmitting the virus to others. The vaccine had a high efficacy of up to 96% early on and this efficacy did not change over time.

Vaccinated individuals are still at risk of getting COVID, but may have milder symptoms. Vaccines were introduced late in the pandemic, and early treatment and natural immunity were key in saving lives. There is controversy over vaccine safety, with reports of deaths following vaccination. Some studies suggest vaccinated individuals are at higher risk of severe outcomes. Calls have been made to remove vaccines from the market due to safety concerns. Translation: Vaccinated people can still get COVID, but may have less severe symptoms. Early treatment and natural immunity were important in saving lives. There are concerns about vaccine safety, with reports of deaths after vaccination. Some studies indicate vaccinated people may be at higher risk of severe outcomes. There are calls to remove vaccines from the market due to safety concerns.

The speaker reflects on the initial excitement and optimism when news broke that the vaccine was 95% effective. They acknowledge that many people, including themselves, wanted to believe that this was the end of the pandemic. However, they admit that perhaps there was too little caution and too much optimism. They highlight that nobody considered the possibility of vaccine effectiveness waning or the potential challenges posed by future variants.

The speakers discuss the effectiveness of COVID-19 vaccines and the importance of getting vaccinated. They emphasize that vaccinated individuals are less likely to get infected, transmit the virus, or experience severe illness. They mention that vaccines slightly reduce transmission but do not completely prevent it. The speakers also mention the possibility of waning immunity over time and suggest that booster shots may be necessary. They encourage everyone to get vaccinated and highlight the goal of achieving high immunity levels to return to normalcy. The plan is for every adult to receive a booster shot.

The massive vaccination of the population likely led to the current situation. The virus has become less virulent, but the vaccine does not provide complete immunity. It protects individuals but does not directly protect the community. However, it indirectly helps protect the community. There is controversy surrounding whether the vaccine prevents transmission, but it is known to prevent severe symptoms in individuals. The vaccine allows individuals to develop a functional immune memory that helps avoid severe forms of the disease.

The speakers emphasize the importance of vaccination in reducing transmission and returning to normalcy. They express confidence in the effectiveness of vaccines, stating that vaccinated individuals do not carry the virus or get sick. Getting vaccinated and receiving booster shots are seen as life-saving measures that protect family and friends from serious illness and infection. The goal is to break the chain of transmission and become a dead end for the virus. Vaccinated individuals do not become infected and cannot spread the virus further. However, it is noted that the initial emergency use authorization did not have sufficient data on the vaccine's impact on transmission. The speed of scientific progress necessitated quick action.

Some people love the vaccines, while others hate them. The speaker acknowledges that vaccines have saved lives, but also mentions concerns about their safety. Reports vary on the effectiveness and problems with the vaccines, but the speaker claims to have saved 100 million lives. They argue that those who get very sick and go to the hospital are usually the ones who haven't taken the vaccine. The mainstream media is accused of stifling information about adverse reactions. The speaker believes the vaccines have saved millions of lives but criticizes the media for pausing the Johnson and Johnson vaccine over a small number of cases.

The speakers discuss the importance of vaccination in reducing transmission and returning to normalcy. They express confidence in the vaccines' ability to prevent illness and transmission. They emphasize the need for people to get vaccinated for their own protection and to break the chain of transmission. Vaccinated individuals are seen as dead ends for the virus, preventing further spread. However, it is mentioned that initial data on vaccine effectiveness against transmission was limited at the time of emergency use authorization. A question is raised about whether the Pfizer vaccine was tested for transmission prevention before its release, to which the response is that they had to move quickly based on scientific progress.

The speaker was upset when the CDC stopped tracking vaccinated people who were infected, suspecting it was to avoid making the vaccine seem ineffective. They believe mandating the vaccines was a mistake and that there should have been more honesty about side effects and the fact that vaccines don't protect against infection. The speaker recalls that while serving as a public health advisor in Maryland, two-thirds of infected individuals had been vaccinated, contrary to claims that it was an epidemic of the unvaccinated. They state the vaccine's efficacy lasts only 4-6 months and that some patients are experiencing long COVID symptoms from the vaccine. In the speaker's opinion, the spike protein is immunotoxic, whether from infection or vaccination. They express concern that mRNA vaccines cause the body to produce an unknown quantity of spike protein for an undetermined duration. They now prefer and use the Novavax protein vaccine, where the amount of spike protein is controlled and its decay curve is known. They believe the mRNA vaccines may cause prolonged spike protein production or negative consequences in some individuals, although it is rare.

Speaker 0 and Speaker 1 discuss the COVID-19 vaccine episode, challenging why the vaccine was pursued as a public health solution and exploring deeper incentives behind the program. - A knowledgeable figure at the stand answered a burning question: did they know the vaccine wouldn’t be effective from the start and could be dangerous? The answer given was that it was “a test of a technology.” The exchange suggests the broader aim was testing an entire program of control previewed in Event 2019. - They ask whether inoculation was necessary on billions, noting it could have been tested on a much smaller population. If shots had been basically empty or inert, the data could have been spun to claim success and end the pandemic, preventing injuries from appearing. The absence of that approach remains a mystery. - The speakers point to high pre-vaccine seroprevalence in 2020, including studies from South Dakota showing 50-60% seroprevalence before vaccine release, implying that a saline shot or no shot could have achieved “indomicity” (immunity) without a vaccine. - They discuss why people might fear vaccines and interpret the broader impact: the public is waking up to something terrible having occurred, as it revealed readiness to lie, potential data quality concerns, and risk to pregnant women and healthy children who might get little justification for risk. - The disease’s lethality is framed as greatest among the very old or very sick; for others, it was less deadly, with natural evolution potentially reducing vulnerability over time. - The mRNA platform was touted as a means to outrun mutations, but the timeline to release was still insufficient to stay ahead of natural change. They note accelerated development was the fastest vaccine in history, from detection to inoculation, reducing the timeline by about a year or two, yet not fast enough. - Political and logistical factors delayed release; there is mention that it would not have appeared under Trump and that Eric Topol argued to delay the rollout. Fauci reportedly sent Moderna back to trials due to insufficient racial diversity in participants. - The discussion questions whether the vaccine qualifies as a normal consumer product, given ongoing subsidies, mandates, indemnifications, wartime-like supports, and propaganda. They wonder if there has been an ongoing two-century revolt by industry against public scrutiny, with public interest repeatedly leading to pushback and rebranding. - A central theme is the sophistication of pharma: the “game of pharma” involves owning an IP-based health claim, crafting supportive research, convincing it is safe and effective, achieving standard-of-care status, securing mandates and government funding, and leveraging ongoing propaganda. They describe pharma as a long-running arms race with deep institutional knowledge, implying that it is far more capable of shaping reality than the public realizes.

The Pfizer COVID vaccine was not tested for its ability to stop the transmission of the virus before it entered the market. The speaker acknowledges that they had to work quickly to understand the situation and move at the speed of science.

The massive vaccination of the population has likely led to the current situation. The virus has become less virulent, but the vaccine does not provide complete immunity. It protects individuals but does not directly protect the community. However, it indirectly helps protect the community. There is controversy surrounding whether the vaccine prevents transmission, but it is known to prevent individual health issues. It has allowed individuals to develop a functional immune memory that helps prevent severe forms of the disease.

The speaker acknowledges that the vaccine did not completely stop the spread or infection, but clarifies that initially it did for the Wuhan strain and the alpha strain. Early data and literature published in the New England Journal showed that those who were vaccinated and didn't get infected were not transmitting the virus to others. The vaccine had a high efficacy of up to 96% early on and this efficacy did not change over time.

The speaker acknowledges that the vaccine did not completely stop the spread or infection, but clarifies that initially it did for the Wuhan strain and the alpha strain. Early data and literature published in the New England Journal showed that those who were vaccinated and didn't get infected were not transmitting the virus to others. The vaccine had a high efficacy of up to 96% early on and this efficacy did not change over time.

We developed vaccines, like the Ameila vaccine, in just nine months. It's fast, considering the uncertainties surrounding vaccines. Initially, we made a mistake by claiming they protect against transmission, but they actually provide limited protection. As a result, repeated vaccinations are necessary due to their relatively short lifespan.

The speaker asked about the long-term effects of the vaccine, but the response was unclear. The speaker mentioned that the effects at one year are known, but not at three to five years. They also mentioned that 93% of the population will be vaccinated. The speaker seemed unsure and mentioned feeling pressured at work.

The speaker discusses the impact of the vaccine on saving lives and acknowledges that there are side effects. They mention that both the virus and the vaccine have changed over the past two years, leading to transmission and infection. However, there is disagreement between the speakers, with one denying the effectiveness of the vaccine. The conversation becomes heated, with one person telling the other to be quiet.